Internal Medicine, Gastroenterology · Hialeah, FL
NPI
1497021331
Since 2012
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2140 W 68th St Ste 300
Hialeah, FL, 33016
Phone (305) 822-4107
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,389
116 services
Medicare patients, 2024
92
Average age 68
Drug cost, 2024
$9.4M
900 prescriptions
Company payments, 2025
$2,240
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vanessa Mendez was code 99214 (office e&m - established), 68 times for 63 patients. In total Vanessa Mendez billed 116 services in 9 codes, and Medicare paid $8,389.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 68 | 63 | $72.05 | $4,899 |
| 99214 Office E&M - Established | Facility | 19 | 19 | $53.06 | $1,008 |
By year: 2022 $8,523 for 106 services; 2023 $14K for 188 services; 2024 $8,389 for 116 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vanessa Mendez prescribed most often to Medicare patients was Stelara (Ustekinumab), with 294 prescriptions and refills. In total Vanessa Mendez wrote 900 Medicare prescriptions that cost $9.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 294 | 341 | 54 | $7.8M |
| Omeprazole Generic | 74 | 168 | 38 | $931 |
| Humira(Cf) Pen Adalimumab | 55 | 55 | 12 | $604K |
| Mesalamine Generic | 53 | 121 | 16 | $26K |
| Pantoprazole Sodium Generic | 39 | 102 | 18 | $288 |
| Dicyclomine Hcl Generic | 31 | 49 | 19 | $688 |
| Rinvoq Upadacitinib | 23 | 23 | Under 11 | $155K |
| Skyrizi On-Body Risankizumab-Rzaa | 20 | 37 | Under 11 | $395K |
| Azathioprine Generic | 18 | 44 | Under 11 | $1,745 |
| Balsalazide Disodium Generic | 18 | 38 | Under 11 | $3,991 |
| Famotidine Generic | 17 | 43 | Under 11 | $572 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 17 | 17 | 16 | $859 |
| Sodium Chloride 0.9 % Sodium Chloride | 16 | 16 | Under 11 | $65.26 |
| Entyvio Vedolizumab | 16 | 24 | Under 11 | $139K |
| Loperamide Loperamide Hcl | 14 | 26 | Under 11 | $447 |
Brand drugs: 521 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vanessa Mendez $2,240 ($2,240 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $544.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $544 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $246 |
| Madrigal Pharmaceuticals MDGL | 6 | $195 |
| QOL Medical, LLC | 9 | $185 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 7 | $181 |
| Janssen Biotech, Inc. JNJ | 8 | $160 |
| Genzyme Corporation SNY | 6 | $153 |
| Lilly USA, LLC LLY | 6 | $104 |
| Aimmune Therapeutics, Inc. | 4 | $68.31 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $60.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.